Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 27, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Contract with the Air Force Research Lab

CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
December 07, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023

- Poster presentation on SYNB1353 program for homocystinuria includes findings from process improvements to improve activity of methionine degradation - CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE...
November 07, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
October 03, 2023 16:15 ET | Source: Synlogic, Inc.

Synlogic Announces Closing of $21.0 Million Underwritten Public Offering

CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
September 29, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering

CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
July 11, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria

CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
June 28, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces International Nonproprietary Name Selection for SYNB1934

The World Health Organization has approved “labafenogene marselecobac”Name attributes recognize Synlogic’s proprietary technology and commitment to phenylketonuria communityCAMBRIDGE, Mass., June...
February 12, 2015 08:31 ET | Source: iBio, Inc.

iBio Receives US and European Patents for Protein Expression Technology

NEWARK, DE--(Marketwired - Feb 12, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issuance of...
February 04, 2015 08:31 ET | Source: iBio, Inc.

iBio Adds to iBioModulator Portfolio and Product Pipeline

NEWARK, DE--(Marketwired - Feb 4, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a new...
December 10, 2014 08:31 ET | Source: iBio, Inc.

iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting

NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and...

Next Page keyboard_arrow_right